Which deficits are described as refractor to antipsychotics in schizophrenia?

Which deficits are described as refractor to antipsychotics in schizophrenia?

• A. Grandiose Delusions
• B. Sleep Disturbances
• C. Motor Abnormalities
• D. Sociocognitive Deficits

Answer: (D)

Sociocognitive deficits tend to be refractorily treated by antipsychotics in schizophrenia. Antipsychotic medications mainly target positive symptoms—delusions and hallucinations—by dampening dopamine activity, but they have limited impact on social cognition and related abilities such as recognizing emotions, understanding others’ mental states, and interpreting social cues. These deficits can persist even when psychotic symptoms are well controlled, and they are a major driver of functional impairment. To improve them, approaches like cognitive remediation and social skills training, alongside psychosocial rehabilitation, are often needed. Grandiose delusions are a type of positive symptom that usually responds to antipsychotics; sleep disturbances may improve with targeted sleep management; motor abnormalities are more about movement-related side effects or other symptom clusters and don’t define the refractoriness described here.

Sociocognitive deficits tend to be refractorily treated by antipsychotics in schizophrenia. Antipsychotic medications mainly target positive symptoms—delusions and hallucinations—by dampening dopamine activity, but they have limited impact on social cognition and related abilities such as recognizing emotions, understanding others’ mental states, and interpreting social cues. These deficits can persist even when psychotic symptoms are well controlled, and they are a major driver of functional impairment. To improve them, approaches like cognitive remediation and social skills training, alongside psychosocial rehabilitation, are often needed. Grandiose delusions are a type of positive symptom that usually responds to antipsychotics; sleep disturbances may improve with targeted sleep management; motor abnormalities are more about movement-related side effects or other symptom clusters and don’t define the refractoriness described here.